Successful propranolol therapy for infantile hepatic hemangioma with cardiac failure.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Infantile hepatic hemangioma (IHH) can cause severe complications such as high-output cardiac failure and growth faltering, requiring prompt diagnosis and intervention. In the absence of standardized treatment guidelines, propranolol has emerged as an effective and well-tolerated therapy. We report a female infant with multifocal IHH who presented with high-output cardiac failure, hepatomegaly, and growth faltering. She experienced rapid and sustained clinical as well as radiologic improvement with propranolol therapy. This case reinforces propranolol's role as a safe, effective first-line therapy for symptomatic IHH and underscores the importance of early multidisciplinary care.